These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11679561)
1. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561 [TBL] [Abstract][Full Text] [Related]
2. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100 [TBL] [Abstract][Full Text] [Related]
3. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878 [TBL] [Abstract][Full Text] [Related]
4. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Jacobsen MD; Whyte JA; Odds FC Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974 [TBL] [Abstract][Full Text] [Related]
5. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method. Pai MP; Jones AL; Mullen CK Diagn Microbiol Infect Dis; 2007 May; 58(1):129-32. PubMed ID: 17240112 [TBL] [Abstract][Full Text] [Related]
6. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. Laverdiere M; Hoban D; Restieri C; Habel F J Antimicrob Chemother; 2002 Jul; 50(1):119-23. PubMed ID: 12096017 [TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058 [TBL] [Abstract][Full Text] [Related]
9. Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum. Kovács R; Saleh Q; Bozó A; Tóth Z; Gesztelyi R; Kardos T; Kardos G; Takacs I; Majoros L Mycopathologia; 2017 Dec; 182(11-12):979-987. PubMed ID: 28699056 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. Fleischhacker M; Radecke C; Schulz B; Ruhnke M Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):127-31. PubMed ID: 18057972 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Ernst EJ; Roling EE; Petzold CR; Keele DJ; Klepser ME Antimicrob Agents Chemother; 2002 Dec; 46(12):3846-53. PubMed ID: 12435687 [TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. Mikamo H; Sato Y; Tamaya T J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180 [TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital]. Komatsu M; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Abe N; Matsuo S Jpn J Antibiot; 2003 Dec; 56(6):705-11. PubMed ID: 15007879 [TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Espinel-Ingroff A Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349 [TBL] [Abstract][Full Text] [Related]
15. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii. Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779 [TBL] [Abstract][Full Text] [Related]
16. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ J Clin Microbiol; 2006 Oct; 44(10):3533-8. PubMed ID: 17021079 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species. Ramírez M; Serrano MC; Castro C; López E; Almeida C; Fernández A; Romero A; Martín-Mazuelos E J Antimicrob Chemother; 2006 Oct; 58(4):861-3. PubMed ID: 16916868 [TBL] [Abstract][Full Text] [Related]
18. In vitro interaction of micafungin and fluconazole against Candida. Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050 [No Abstract] [Full Text] [Related]
19. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. Uchida K; Nishiyama Y; Yokota N; Yamaguchi H J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964 [TBL] [Abstract][Full Text] [Related]
20. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Seidler M; Salvenmoser S; Müller FM Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]